The global industry was valued at US$ 8.3 Bn in 2022 and is estimated to grow at a CAGR of 5.5% from 2023 to 2031, reaching US$ 13.5 Bn by the end of 2031. The glaucoma therapeutics market is experiencing steady growth as the global burden of eye-related disorders continues to rise, particularly among aging populations. Glaucoma, one of the leading causes of irreversible blindness...